ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007

In Brief: Frederickson Resigns As NIH Director, Says He Wants “One More Career: As Scientist, Physician

June 25, 1981

2015: “A Challenge For Our Generation,” AACR Says

July 18, 2003

NCI Progress: Biomarker Labratories Funded To Develop Early Detection Methods

October 22, 1999

St. Jude Considers Relocating to Washington U.

August 9, 1985